Related Experiment Video

Updated: May 30, 2026

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

Microparticles: targets and tools in cardiovascular disease

Maria Carmen Martinez1, Simon Tual-Chalot, Daniela Leonetti

  • 1Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 694, Faculté de Médecine, Université d'Angers, Angers, France.

Trends in Pharmacological Sciences
|July 29, 2011
PubMed

Insights

Microparticles (MPs) are released from cells and can cause cell dysfunction, contributing to cardiovascular diseases. Targeting MPs offers potential therapeutic strategies for these conditions.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Cardiovascular Science

Background:

  • Cells communicate through direct contact, signaling molecules, and microparticles (MPs).
  • MPs are small vesicles released from stimulated or apoptotic cells, carrying parent cell characteristics and signaling components.
  • MPs act as biomarkers and effectors of cell signaling, potentially initiating or maintaining cell dysfunction.

Purpose of the Study:

  • To review the mechanisms of microparticle formation.
  • To discuss the effects of microparticles on target cells in physiological and pathophysiological conditions.
  • To explore therapeutic strategies involving microparticles for cardiovascular pathologies.

Main Methods:

  • Literature review of microparticle formation mechanisms.
  • Analysis of microparticle effects on endothelial cells and vascular inflammation.
  • Exploration of pharmacological and engineered microparticle-based therapies.

Main Results:

  • Microparticles can evoke endothelial dysfunction by reducing nitric oxide (NO) production.
  • Microparticles promote vascular inflammation, contributing to a prothrombotic state in atherosclerosis.
  • Microparticles are implicated in maintaining and initiating cell dysfunction.

Conclusions:

  • Microparticle production and properties present novel therapeutic targets for cardiovascular diseases.
  • Engineered microparticles with modified compositions may serve as therapeutic agents.
  • Understanding microparticle formation and function is crucial for treating cardiovascular pathologies.

More Related Videos

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans08:21

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Published on: July 21, 2023

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...